Comments on "Comparison of repaglinide and metformin versus metformin alone for type 2 diabetes: a meta-analysis of randomized controlled trials"

Diabetes Res Clin Pract. 2015 Apr;108(1):e1-2. doi: 10.1016/j.diabres.2015.02.004. Epub 2015 Feb 21.

Authors

De-Qi Jiang¹, Ming-Xing Li², Yong Wang³

Affiliations

¹ Department of Pharmacy, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China; Department of Biopharmaceutical, Yulin Normal University, Yulin 537000, China.
² Department of Pharmacy, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China.
³ Department of Pharmacy, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China. Electronic address: yongwh2005@hotmail.com.

PMID: 25747159
DOI: 10.1016/j.diabres.2015.02.004

No abstract available

Publication types

Letter
Comment

MeSH terms

Carbamates / therapeutic use*
Diabetes Mellitus, Type 2 / drug therapy*
Humans
Hypoglycemic Agents / therapeutic use*
Metformin / therapeutic use*
Piperidines / therapeutic use*

Substances

Carbamates
Hypoglycemic Agents
Piperidines
Metformin